10/06/2017 | Nexagen, LLC | Atlanta District Office | CGMP/Dietary Supplement/Adulterated | Not Issued * |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, October 31, 2017
10/16/2017 | Kim Chemicals Private Ltd. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug | Not Issued * |
10/17/2017 | Town and Country Compounding and Consultation Services, LLC | New Jersey District Office | Compounding Pharmacy/Adulterated Drug Products | Not Issued * |
10/18/2017 | Accelerated Analytical Laboratories Inc. | Detroit District Office | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued * |
10/20/2017 | Aztex Enterprises Ltd. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued * |
10/23/2017 | Panther Sports Nutrition | New Jersey District Office | Unapproved New Drugs/Misbranded | Not Issued * |
Do Biosimilars Require Clinical Trials?
Applied Clinical Trials Online (press release) (blog)-Oct 30, 2017
FDA has mapped out a development pathway for biosimilars that relies primarily on structural analysis and preclinical and clinical pharmacology studies to ...
Drugmaker set to profit from an opioid it said was unsafe
WGNO-Oct 30, 2017
Endo contended that the new Opana ER and its hard coating deterred abuse, but this summer, the FDA disagreed. In June, the regulatory agency concluded that ...
Endo to receive royalties from generic opioid it once called 'unsafe ...
Becker's Hospital Review-21 hours ago
Becker's Hospital Review-21 hours ago
Par Pharma Suit Tests FDA's Drug Pricing Pushback
Par Pharma Suit Tests FDA's Drug Pricing Pushback
Law360-14 hours ago
It accuses the FDA of creating an "unlawful regime" that will allow compounders to churn out huge quantities of blood-pressure drug vasopressin, despite Par ...
Endo files lawsuit to obtain FDA compliance with Drug Quality and ...
The Pharma Letter-30 minutes ago
"Endo welcomes FDA Commissioner Gottlieb's September 2017 press statement that FDA is working on a new compounding policy which we hope will include ...
Monday, October 30, 2017
Flurry Of Federal And State Probes Target Insulin Drugmakers And ...
Flurry Of Federal And State Probes Target Insulin Drugmakers And ...
Bonner County Daily Bee-5 hours ago
Insulin makers Eli Lilly, Novo Nordisk, Sanofi and top pharmacy benefit manager CVS Health are targets in the state investigations. Several of the financial filings ...
Updated List of Countries Viewing Blog 10/30/2017
Albania
Algeria
Angola
Antigua and Barbuda
Guam
Zimbabwe
Algeria
Angola
Antigua and Barbuda
Argentina
Armenia
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladen
Bahrain
Bangladen
Bangladesh
Barbados
Belarus
Belarus
Belgium
Benin
Bermuda
Bermuda
Bosina & Herzegovina
Brazil
Brunei
Brunei
Bulgaria
Burkina Faso
Canada
Cameroon
Burkina Faso
Canada
Cameroon
Cayman Islands
Chile
China
Columbia
Congo (Republic)
Congo (Republic)
Costa Rica
Cote d'lvoire
Croatia
Cyprus
Czech Republic
Czechia
Czechia
Egypt
Estonier
Ethiopia
Falkland Islands (Islas Malvinas)
French Polynesia
Ethiopia
Falkland Islands (Islas Malvinas)
French Polynesia
Fiji
Finland
France
Gabon
Georgia
Greece
Georgia
Greece
Guatemala
Germany
Ghana
GuadeloupeGhana
Guam
Holland
Hong Kong
Honduras
Hungary
India
Indonesia
Iran
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Kazakhstan
Kenya
Latvia
Lithuania
Laos
Luxembourg
Macau
Lithuania
Laos
Luxembourg
Macau
Macedonia
Malaysia
Malta
Maredonia Fyrom
Mauritius
Maredonia Fyrom
Mauritius
Mexico
Micronesia
Moldavo
Mongolia
Montenegro
Montenegro
Morocco
Mozambique
Mozambique
Nepal
Netherlands
Netherlands Antilles
New Zealand
Nicaragua
Nicaragua
Nigeria
Norway
Norway
Oman
Pakistan
Panama
Philippines
Poland
Puerto Rico
Peru
Portugal
Qatar
Romania
Reunion
Romania
Reunion
Russia
Saudi Arabia
Senegal
Senegal
Serbia
Seychelles
Singapore
Sint Maarten
Sint Maarten
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Suriname
Sri Lanka
Suriname
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Tunisia
Turkey
Turks and Cacaos
Turkmenistan
Turkmenistan
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Venezuela
Vietnam
DEA Hiring Diversion Investigators Again
Diversion Investigator (Recent Graduate)
Drug Enforcement Administration
Department of Justice
DEA - US Locations, United States
- Starting at $35,359 (GS 07-09)
- Permanent • Full Time
Open 10/30/2017 to 11/03/2017
Work pressure a factor in Boots pharmacist's death
Australian Journal of Pharmacy (blog)-7 hours ago
Local member of Parliament Kevan Jones had been contacted by the family of Alison Stamps, a “young and talented” pharmacist who lost her life to suicide after ...
Aussie pharmacy giant Chemist Warehouse tipped to open first NZ ...
New Zealand Herald-11 hours ago
Australia pharmacy giant Chemist Warehouse is tipped to open its first New Zealand store this week. The Auckland store is set open in St Luke's Wagener Place ...
California confronts opioid addiction, an 'epidemic of despair'
CALmatters-10 hours ago
Compounding the issue in rural areas that the economic recovery didn't reach ... Eventually, he found someone who worked in a pharmacy and sold him the pills .
FDA Law Blog - Is FDA’s Interim Policy on Section 503B’s So-Called “Bulks List 1” Illegal? Did FDA Overstep its Statutory Authority? The U.S. District Court for the District of Columbia May Soon Decide…. Is FDA’s Interim Policy on Section 503B’s So-Called “Bulks List 1” Illegal? Did FDA Overstep its Statutory Authority? The U.S. District Court for the District of Columbia May Soon Decide…. Posted: 29 Oct 2017 02:46 PM PDT By Karla L. Palmer – On October 26, 2017,
Sunday, October 29, 2017
Kudos to Florida Board of Pharmacy on their Excellent Website and Ease of Finding Meeting Information. Next Meeting November 3, 2017 Multidisciplinary Board Fact Finding Workgroup on Controlled Substances
Next Meeting:
November 3, 2017
Multidisciplinary Board Fact Finding Workgroup on Controlled Substances
Meeting Location:
Orlando, FL 32819Rosen Plaza Hotel 9700 International Drive Date | Meeting Type | Materials |
November 16, 2017 | Probable Cause Panel | FAR Notice (PDF) | Agenda (PDF) |
November 30, 2017 | Probable Cause Panel | FAR Notice (PDF) | |
December 11, 2017 | Rules Committee | FAR Notice (PDF) | |
December 11, 2017 | Legislative Committee | FAR Notice (PDF) | |
December 12, 2017 | Compounding Committee Meeting | FAR Notice (PDF) | |
December 12, 2017 | Controlled Substance Standards Committee | FAR Notice (PDF) | |
December 11 - December 13, 2017 | Board Meeting | FAR Notice (PDF) | |
Saturday, October 28, 2017
How Much Can Amazon Make In The PBM Business?
How Much Can Amazon Make In The PBM Business?
Seeking Alpha-14 hours ago
Investment Thesis: To assess the value of the Pharmacy Benefits Manager (NYSEMKT:PBM) business to Amazon (AMZN) we analyzed the margins of the ..
Amazon Granted Wholesale Pharmacy Licenses Fueling RX Drug .
Amazon Granted Wholesale Pharmacy Licenses Fueling RX Drug ...
Hot Hardware-12 hours ago
It seems that soon Amazon could be expanding its offerings with pharmacy items, as it has now gained wholesale pharmacy licenses in what is seemingly ...
Central Kentucky pharmacist sentenced to 8 years for distributing painkillers
Central Kentucky pharmacist sentenced to 8 years for drug ...
Lexington Herald Leader-13 hours ago
A Central Kentucky pharmacist who owned and operated Hometown Pharmacy of Georgetown was sentenced Friday to eight years in federal prison for ...
Amazon's Push Into Pharmacy Business Is Full of Promise and Pitfalls
Amazon's Push Into Pharmacy Business Is Full of Promise and Pitfalls
Wall Street Journal-17 hours ago
A move by Amazon.com Inc. AMZN 13.22% into the $412 billion pharmacy business would shake up how generations have gotten their medicines, but success ...
Great Read! CVS is plotting a $66 billion takeover — and it has a lot to do with ...
CVS is plotting a $66 billion takeover — and it has a lot to do with ...
Markets Insider-12 hours ago
Speculation that Amazon might be getting into the pharmacy business has been rampant for months — and it came to a head, coincidentally, on Thursday when ...
Here's Why Endo International Stock Dropped as Much as 13.8
Here's Why Endo International Stock Dropped as Much as 13.8 ...
Madison.com-17 hours ago
What the heck is bulk compounding? A pharmaceutical drug is essentially comprised of two components: the active pharmaceutical ingredient, or API (the ...
Friday, October 27, 2017
Endo moves to protect Vasostrict franchise with FDA lawsuit; shares ...
Seeking Alpha-10 hours ago
Category 1-listed products can be freely compounded because they do not present a significant safety risk in compounding. Endo Chief Legal Officer Matthew .
Here's why CVS wants to buy Aetna for $66 billion
Chicago Tribune-3 hours ago
CVS Health is reportedly in talks to buy the nation's third largest health insurer, Aetna, in a deal that would allow the pharmacy giant to expand into an entirely ...
CVS Health introduces safe medication disposal inside CVS ...
Pharmacy Today, American Pharmacists Association, pharmacist.com-4 hours ago
Pharmacy Today, American Pharmacists Association, pharmacist.com-4 hours ago
Subscribe to:
Posts (Atom)